3 Key Trends to Consider for Oncology Management by Rebecca Borgert June 5, 2019Cancer, Cancer treatment, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit Drug Management, Medical Oncology Spend, Novel Cancer Drugs, Oncology, Oncology Biosimilars, Oncology Management
What do Employers Need to Know about Escalating Specialty Drug Spend? by Kathy Campagna May 24, 2017Autoimmune, Employers, Magellan Rx Management, Medical Benefit, Oncology, PBM, Rare Diseases, Specialty Pharmacy
Six Ways to Keep Specialty Spend Under Control by Magellan Health Insights March 31, 2017Magellan Rx Management, Matt Ward, Medical Pharmacy, Oncology, PBM, Pharmacy Benefits Management, Specialty Pharmacy
A Value-Based PBM: Implications for Various Stakeholders by Magellan Health Insights October 13, 2016Dr. Karen Amstutz, Dr. Maria Lopes, Magellan Health, Magellan Rx Management, Oncology, PBM, Pharmacy, Pharmacy Benefit Management, Specialty Pharmacy, Value-Based
